Jobs at Cogent Biosciences

Who We Are Cogent Biosciences is a publicly traded biotechnology company focused on developing precision therapies for genetically defined diseases. The most advanced clinical program, bezuclastinib, is a selective tyrosine kinase inhibitor that is designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. KIT D816V is responsible for driving systemic mastocytosis (SM), a serious disease caused by unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with strong dependence on oncogenic KIT signaling. Top-line results from registration-directed trials in NonAdvanced SM, Advanced SM and GIST are expected in 2025. The company also has an ongoing Phase 1 study of its novel internally discovered FGFR2 inhibitor. In addition, the Cogent Research Team is developing a portfolio of novel targeted therapies to help patients fighting serious, genetically driven diseases targeting mutations in ErbB2, PI3Kα and KRAS. Our Team https://cogent.culturehq.com

cogent.culturehq.com

Open positions (1)

6 days ago

Clinical Account Manager - Charlotte, NC

Charlotte, NC

$200,000-$240,000 / year

You will serve as a critical member of the Customer Engagement Team with an opportunity to potentially launch Bezuclastinib in multiple indications across three disease states. You will be responsible for meeting sales targets and utilizing all available resources while tailoring them to meet customer needs through a deep understanding of their requirements. This role requires collaboration, communication, planning, relationship building, and the ability to execute tactical initiatives and provide timely feedback.

full-timesenior RemoteBiotechnology